Protocol for the specified clinical experience investigation on the single use of Casodex® Tablet 80 mg - CAMON

Study identifier:NIS-OJP-CAS-2009/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Protocol for the specified clinical experience investigation on the single use of Casodex® Tablet 80 mg

Medical condition

prostate cancer

Phase

-

Healthy volunteers

No

Study drug

-

Sex

Male

Actual Enrollment

712

Study type

Observational

Age

N/A

Date

Study Start Date: 01 May 2009
Primary Completion Date: 01 Mar 2012
Study Completion Date: 01 Mar 2012

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria